Last update 12 Aug 2026

ZHB107-108

Overview

Basic Info

Drug Type
Biological products
Synonyms
ZHB A001, ZHB-A001, ZHB107-108
Target-
Action-
Mechanism-
Therapeutic Areas
Immune System DiseasesInfectious DiseasesOtorhinolaryngologic Diseases+ [1]
Active Indication
Allergic asthmaHouse dust mite allergyRhinitis, Allergic, Perennial+ [2]
Inactive Indication-
Originator Organization
Zonhon Biopharma Institute, Inc.Zonhon Biopharma Institute, Inc.
Active Organization
Zonhon Biopharma Institute, Inc.Zonhon Biopharma Institute, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with ZHB107-108
CTR20233750
/ CompletedPhase 1
ZHB107-108舌下片在尘螨过敏引起的过敏性鼻炎（伴或不伴结膜炎）的中国成人受试者中随机、双盲、安慰剂对照、剂量递增给药的耐受性及安全性研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalation study of the tolerability and safety of ZHB107-108 sublingual tablets in Chinese adult subjects with allergic rhinitis (with or without conjunctivitis) caused by dust mite allergy
CTR20233751
/ RecruitingPhase 1
ZHB107-108舌下片在尘螨过敏引起的过敏性哮喘（伴或不伴过敏性鼻炎）的中国成人受试者中随机、双盲、安慰剂对照、剂量递增给药的耐受性及安全性研究
[Translation] A randomized, double-blind, placebo-controlled, dose-escalation study of the tolerability and safety of ZHB107-108 sublingual tablets in Chinese adult subjects with allergic asthma (with or without allergic rhinitis) caused by dust mite allergy
CTR20262902
/ Not yet recruitingPhase 2
ZHB107-108舌下片治疗尘螨过敏引起的成人过敏性鼻炎或鼻结膜炎（伴或不伴过敏性哮喘）患者的有效性和安全性研究
[Translation] A study on the efficacy and safety of ZHB107-108 sublingual tablets in treating adult patients with allergic rhinitis or rhinoconjunctivitis (with or without allergic asthma) caused by dust mite allergy.
100 Clinical Results associated with ZHB107-108
Login to view more data
100 Translational Medicine associated with ZHB107-108
Login to view more data
100 Patents (Medical) associated with ZHB107-108
Login to view more data
100 Deals associated with ZHB107-108
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Allergic asthmaPhase 2
China
Zonhon Biopharma Institute, Inc.Zonhon Biopharma Institute, Inc.
12 Aug 2026
House dust mite allergyPhase 2
China
Zonhon Biopharma Institute, Inc.Zonhon Biopharma Institute, Inc.
12 Aug 2026
Rhinitis, Allergic, PerennialPhase 2
China
Zonhon Biopharma Institute, Inc.Zonhon Biopharma Institute, Inc.
12 Aug 2026
RhinoconjunctivitisPhase 2
China
Zonhon Biopharma Institute, Inc.Zonhon Biopharma Institute, Inc.
12 Aug 2026
allergic rhinitis due to dust mitePhase 1
China
Zonhon Biopharma Institute, Inc.Zonhon Biopharma Institute, Inc.
27 Mar 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free